185 related articles for article (PubMed ID: 37943878)
1. Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth.
He A; Tian S; Kopper O; Horan DJ; Chen P; Bronson RT; Sheng R; Wu H; Sui L; Zhou K; Tao L; Wu Q; Huang Y; Shen Z; Han S; Chen X; Chen H; He X; Robling AG; Jin R; Clevers H; Xiang D; Li Z; Dong M
PLoS Biol; 2023 Nov; 21(11):e3002353. PubMed ID: 37943878
[TBL] [Abstract][Full Text] [Related]
2. Frizzled receptors (FZDs) in Wnt signaling: potential therapeutic targets for human cancers.
Liu HY; Sun XJ; Xiu SY; Zhang XY; Wang ZQ; Gu YL; Yi CX; Liu JY; Dai YS; Yuan X; Liao HP; Liu ZM; Pang XC; Li TC
Acta Pharmacol Sin; 2024 Apr; ():. PubMed ID: 38632318
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for recognition of frizzled proteins by
Chen P; Tao L; Wang T; Zhang J; He A; Lam KH; Liu Z; He X; Perry K; Dong M; Jin R
Science; 2018 May; 360(6389):664-669. PubMed ID: 29748286
[No Abstract] [Full Text] [Related]
4. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into Wnt signaling inhibition by Clostridium difficile toxin B.
Chen P; Tao L; Liu Z; Dong M; Jin R
FEBS J; 2019 Mar; 286(5):874-881. PubMed ID: 30347517
[TBL] [Abstract][Full Text] [Related]
6. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
Zhang X; Zhang R; Hou C; He R; Wang QS; Zhou TH; Li XQ; Zhai QL; Feng YM
J Biol Chem; 2022 Jul; 298(7):102082. PubMed ID: 35660418
[TBL] [Abstract][Full Text] [Related]
7. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.
Tao L; Zhang J; Meraner P; Tovaglieri A; Wu X; Gerhard R; Zhang X; Stallcup WB; Miao J; He X; Hurdle JG; Breault DT; Brass AL; Dong M
Nature; 2016 Oct; 538(7625):350-355. PubMed ID: 27680706
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists.
Yin P; Wang W; Zhang Z; Bai Y; Gao J; Zhao C
Cancer Sci; 2018 Nov; 109(11):3368-3375. PubMed ID: 30137666
[TBL] [Abstract][Full Text] [Related]
9. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
11. Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology.
Pan Z; Zhang Y; Luo J; Li D; Zhou Y; He L; Yang Q; Dong M; Tao L
PLoS Pathog; 2021 Jan; 17(1):e1009197. PubMed ID: 33507919
[TBL] [Abstract][Full Text] [Related]
12. Frizzled Receptors in Tumors, Focusing on Signaling, Roles, Modulation Mechanisms, and Targeted Therapies.
Sun Y; Wang W; Zhao C
Oncol Res; 2021 Mar; 28(6):661-674. PubMed ID: 32998794
[TBL] [Abstract][Full Text] [Related]
13. Paracrine Wnt signaling both promotes and inhibits human breast tumor growth.
Green JL; La J; Yum KW; Desai P; Rodewald LW; Zhang X; Leblanc M; Nusse R; Lewis MT; Wahl GM
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6991-6. PubMed ID: 23559372
[TBL] [Abstract][Full Text] [Related]
14. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
[TBL] [Abstract][Full Text] [Related]
15. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
[TBL] [Abstract][Full Text] [Related]
16. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
[No Abstract] [Full Text] [Related]
17. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
18. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
19.
Flanagan DJ; Barker N; Costanzo NSD; Mason EA; Gurney A; Meniel VS; Koushyar S; Austin CR; Ernst M; Pearson HB; Boussioutas A; Clevers H; Phesse TJ; Vincan E
Cancer Res; 2019 Mar; 79(5):970-981. PubMed ID: 30622113
[TBL] [Abstract][Full Text] [Related]
20. MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists.
Lv C; Li F; Li X; Tian Y; Zhang Y; Sheng X; Song Y; Meng Q; Yuan S; Luan L; Andl T; Feng X; Jiao B; Xu M; Plikus MV; Dai X; Lengner C; Cui W; Ren F; Shuai J; Millar SE; Yu Z
Nat Commun; 2017 Oct; 8(1):1036. PubMed ID: 29051494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
